https://cvvr.hms.harvard.edu/wp-content/uploads/2017/10/honor-2-MG_7243.jpeg16672500Academic Web Pageshttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngAcademic Web Pages2017-10-27 15:08:002019-12-29 10:48:49Dr. Dan Barouch Honored by the Massachusetts Society for Medical Research as Investigator of the Year
It takes a cocktail of drugs to treat HIV. It could take a cocktail of antibodies to prevent HIV as well, suggests a study in Science Translational Medicine by Boston-based researchers […]
https://cvvr.hms.harvard.edu/wp-content/uploads/2017/09/HIVVirus-1000x695-1.jpg6951000Academic Web Pageshttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngAcademic Web Pages2017-09-22 16:00:002019-12-29 10:55:55WBUR Interview: HIV Prevention Could Need Cocktail Of Antibodies
https://cvvr.hms.harvard.edu/wp-content/uploads/2017/09/092017_AC_HIV-antibodies_main.jpg460860Academic Web Pageshttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngAcademic Web Pages2017-09-20 18:30:002019-12-29 11:01:13By Ganging Up, HIV Antibodies May Defeat the Virus
https://cvvr.hms.harvard.edu/wp-content/uploads/2017/09/Zika_1.jpg7721200Academic Web Pageshttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngAcademic Web Pages2017-09-06 19:41:002019-12-29 11:06:16Experimental Study Says Zika May Be Able to Treat Brain Cancer
By Carey Goldberg WBUR At a major international AIDS conference in Paris this week, researchers presented findings on a new HIV vaccine that look promising enough to launch a big clinical […]
https://cvvr.hms.harvard.edu/wp-content/uploads/2017/07/image-asset.jpeg6671000Academic Web Pageshttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngAcademic Web Pages2017-07-26 19:57:002019-12-29 11:09:13‘Mosaic’ HIV Vaccine Looks Good In Early Trial, Boston Researcher Tells AIDS Conference
A new study found zero transmission of HIV between more than 370 homosexual couples. Preventing new infections while a vaccine is developed is key to controlling the epidemic.
https://cvvr.hms.harvard.edu/wp-content/uploads/2017/07/image-asset-1.jpeg281500Academic Web Pageshttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngAcademic Web Pages2017-07-25 12:56:002019-12-29 11:10:20More evidence treatment zeroes HIV transmission during sex while the world awaits a vaccine
https://cvvr.hms.harvard.edu/wp-content/uploads/2017/07/download.jpg378500Academic Web Pageshttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngAcademic Web Pages2017-07-24 15:55:002019-12-29 11:11:16There’s a promising new HIV vaccine candidate in the pipeline
https://cvvr.hms.harvard.edu/wp-content/uploads/2017/07/20170724-vaccine-hiv.jpg11561157Academic Web Pageshttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngAcademic Web Pages2017-07-24 14:30:002019-12-29 11:13:53Experimental HIV vaccine regimen is well-tolerated, elicits immune responses
Beth Israel Deaconess Medical Center Press Release
Mosaic-based vaccine includes characteristics from several common strains of HIV.
In the APPROACH multi-site, randomized and controlled study of 393 healthy people in five countries, investigational vaccines were well-tolerated and elicited antibody responses in 100 percent of volunteers.
https://cvvr.hms.harvard.edu/wp-content/uploads/2018/07/HIVimage.jpg533800Academic Web Pageshttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngAcademic Web Pages2017-07-24 14:00:002019-12-29 11:13:38Investigational Preventative HIV Vaccine Well-Tolerated, Elicited Antibody Responses in Early Clinical Trials
By Jennifer Graham Johnson & Johnson, July 19th, 2017
As the International AIDS Society Conference on HIV Science kicks off in Paris on July 23, we’re spotlighting researchers who’ve dedicated their life’s work to tackling the epidemic in groundbreaking ways.
https://cvvr.hms.harvard.edu/wp-content/uploads/2017/07/Capture.png3491158Academic Web Pageshttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngAcademic Web Pages2017-07-19 15:58:002019-11-06 11:17:124 Amazing Men and Women at the Forefront of HIV Work
Dr. Dan Barouch Honored by the Massachusetts Society for Medical Research as Investigator of the Year
/in NewsWBUR Interview: HIV Prevention Could Need Cocktail Of Antibodies
/in NewsIt takes a cocktail of drugs to treat HIV. It could take a cocktail of antibodies to prevent HIV as well, suggests a study in Science Translational Medicine by Boston-based researchers […]
By Ganging Up, HIV Antibodies May Defeat the Virus
/in NewsExperimental Study Says Zika May Be Able to Treat Brain Cancer
/in News‘Mosaic’ HIV Vaccine Looks Good In Early Trial, Boston Researcher Tells AIDS Conference
/in NewsBy Carey Goldberg WBUR At a major international AIDS conference in Paris this week, researchers presented findings on a new HIV vaccine that look promising enough to launch a big clinical […]
More evidence treatment zeroes HIV transmission during sex while the world awaits a vaccine
/in NewsA new study found zero transmission of HIV between more than 370 homosexual couples. Preventing new infections while a vaccine is developed is key to controlling the epidemic.
There’s a promising new HIV vaccine candidate in the pipeline
/in NewsThe “mosaic vaccine” tackles the virus’s incredible genetic diversity.
Experimental HIV vaccine regimen is well-tolerated, elicits immune responses
/in NewsResults from early-stage NIH-funded trial support further development of candidate vaccines.
Investigational Preventative HIV Vaccine Well-Tolerated, Elicited Antibody Responses in Early Clinical Trials
/in NewsMosaic-based vaccine includes characteristics from several common strains of HIV.
In the APPROACH multi-site, randomized and controlled study of 393 healthy people in five countries, investigational vaccines were well-tolerated and elicited antibody responses in 100 percent of volunteers.
4 Amazing Men and Women at the Forefront of HIV Work
/in NewsAs the International AIDS Society Conference on HIV Science kicks off in Paris on July 23, we’re spotlighting researchers who’ve dedicated their life’s work to tackling the epidemic in groundbreaking ways.